Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : escalon medical(esmc) -- Ignore unavailable to you. Want to Upgrade?

To: Stefan Habermayer who wrote (24)	12/31/1998 12:02:00 PM
From: Jack Siegel	Read Replies (1) \| Respond to of 27

It has my attention. Five profitable quarters, strong management, and market growth through acquisition and R&D makes Escalon a buy for me. The recent deal with Vascular Dynamics will bring an immediate revenue stream and solid prospects for growth. Even without any marketing or sales support for their Doppler needle technology, Vascular sold product; connecting a proven (and necessary) product with seasoned sales support should increases sales even more. OEM business is increasing, and new proprietary products are in the chute. ESMC is in the black to stay. Still skeptical about the laser connection, however. Comments for the new year? JS